Arrowhead Pharmaceuticals, Inc. (ARWR) Analyst Forecast

$0.00

$0 (0%)
Last update: 07:00 PM EST
Day's range
$57.07
Day's range
$60.97

Recent Analyst Forecasts and Stock Ratings

Date Brokerage Firm Analyst Name Price Target Price when Posted Upside/Downside
on Report Date
Details
09/24/2026 Goldman Sachs Andrea Newkirk $74.00 $66.96   10.51%
08/31/2026 RBC Capital Luca Issi $100.00 $82.32   21.48%
07/23/2026 Piper Sandler Edward Tenthoff $126.00 $88.70   42.05%
07/22/2026 Chardan Capital Keay Nakae $115.00 $91.03   26.33%
07/13/2026 Stifel Nicolaus James Condulis $98.00 $74.11   32.24%
01/02/2026 Tudor Pickering William Pickering $35.00 $66.39   -47.28%
12/17/2025 Piper Sandler Edward Tenthoff $100.00 $64.66   54.66%
11/29/2024 Bernstein William Pickering $24.00 $25.81   -7.02%
11/27/2024 Loop Capital Markets Keay Nakae $60.00 $12.90   365.12%
09/03/2024 Citigroup David Lebowitz $27.00 $22.91   17.85%
07/05/2024 H.C. Wainwright Patrick Trucchio $60.00 $12.77   369.85%
06/04/2024 Goldman Sachs Andrea Tan $31.00 $25.29   22.58%
05/30/2024 RBC Capital Luca Issi $50.00 $11.43   337.45%

Arrowhead Pharmaceuticals Inc. FAQ's

Arrowhead Pharmaceuticals Inc. has been rated by research analysts at Goldman Sachs, RBC Capital, H.C. Wainwright, Stifel Nicolaus, Morgan Stanley, Piper Sandler in the past 90 days.